Real-time data

Listing exchange

NASDAQ Stock Exchange

Price

$8.78

Day High

$9.12

Day Low

$8.5

Day Open

$8.56

Volume

28008

Day Change

0.8%

Latest news data for ACRS

Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences

Aclaris Therapeutics, Inc. (ACRS) Q1 2023 Earnings Call Transcript

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates

Aclaris Therapeutics GAAP EPS of -$0.42 beats by $0.02, revenue of $2.53M beats by $0.78M (NASDAQ:ACRS)

Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update

Aclaris Therapeutics to Announce First Quarter 2023 Financial Results on May 8, 2023

Seborrheic keratosis treatment market size to grow by USD 786.38 million between 2021 and 2026; Aclaris Therapeutics Inc., BioLineRx Ltd., among others, identified as key vendors - Technavio

Aclaris Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

Global Alopecia Market Size To Grow USD 13.7 Billion By 2030 | CAGR 7.7%

Aclaris Therapeutics (ACRS) Stock: Potential Speculative Play

News sentiment (24 hrs)

Intraday data

Historical data

maximum of 5 years displayed, 40+ years of data available via API